Dec 13 (Reuters) - Regis Healthcare Ltd (REG) :
- NON-CASH IMPACT OF REMOVAL OF AGED CARE APPROVAL ROUNDS
- TALKS WITH DEPARTMENT OF HEALTH ONGOING ON PRACTICAL IMPLICATIONS OF DISCONTINUATION OF AGED CARE APPROVAL ROUNDS
- EXPECTS TO AMORTISE VALUE OF BED LICENCES ON A STRAIGHT LINE BASIS OVER THEIR REMAINING ECONOMIC LIFE TO 1 JULY 2024
- SEES REMOVAL OF AGED CARE APPROVAL ROUNDS RESULT IN AFTER TAX AMORTISATION EXPENSE FOR FY22 A$43.5 MILLION, NET OF TAX (9 MONTHS)
- SEES REMOVAL OF AGED CARE APPROVAL ROUNDS RESULT IN AFTER TAX AMORTISATION EXPENSE FOR FY23 OF A$58 MILLION, NET OF TAX
- NOT EXPECTED NON-CASH AMORTISATION OF BED LICENCES WILL, IN ITSELF, LIMIT ABILITY TO PAY DIVIDENDS
- SEES REMOVAL OF AGED CARE APPROVAL ROUNDS RESULT IN AN AFTER TAX AMORTISATION EXPENSE FOR FY24 OF A$58.0 MILLION, NET OF TAX
- Forums
- ASX - By Stock
- REG
- News: REG Regis Healthcare Says Assessing Impact Of Aged Care Approval Rounds Removal
REG
regis healthcare limited
Add to My Watchlist
0.91%
!
$7.79

News: REG Regis Healthcare Says Assessing Impact Of Aged Care Approval Rounds Removal
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$7.79 |
Change
0.070(0.91%) |
Mkt cap ! $2.346B |
Open | High | Low | Value | Volume |
$7.72 | $7.81 | $7.69 | $4.984M | 641.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 20000 | $7.77 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$7.81 | 3563 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 70 | 7.650 |
1 | 6543 | 7.640 |
2 | 1014 | 7.600 |
1 | 27 | 7.570 |
1 | 132 | 7.550 |
Price($) | Vol. | No. |
---|---|---|
7.840 | 263 | 1 |
7.920 | 15000 | 1 |
7.940 | 299 | 1 |
7.950 | 3000 | 1 |
8.000 | 620 | 2 |
Last trade - 16.10pm 05/09/2025 (20 minute delay) ? |
Featured News
REG (ASX) Chart |
The Watchlist
PSC
PROSPECT RESOURCES LIMITED
Sam Hosack, MD & CEO
Sam Hosack
MD & CEO
SPONSORED BY The Market Online